Radiofarmaka 2027 SLL453

Summary

Region Stockholm is procuring radiopharmaceutical products (radioactive medicinal products for diagnostic and therapeutic use) for 2027 onwards, with an estimated contract value of SEK 30 million. The procurement is conducted as an open procedure and targets suppliers authorised to manufacture and distribute radiopharmaceuticals under applicable pharmaceutical legislation. The deadline for bids is 9 November 2026. Relevance depends on your status as a licensed radiopharmaceutical supplier; this procurement requires regulatory approvals and specialist expertise in nuclear medicine.